- Home
- TLSI vs QIPT Comparison
TLSI vs QIPT Comparison
Compare TLSI & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- QIPT
- Stock Information
- Founded
- TLSI 2010
- QIPT 1993
- Country
- TLSI United States
- QIPT United States
- Employees
- TLSI N/A
- QIPT N/A
- Industry
- TLSI Medical Specialities
- QIPT
- Sector
- TLSI Health Care
- QIPT
- Exchange
- TLSI Nasdaq
- QIPT Nasdaq
- Market Cap
- TLSI 204.0M
- QIPT 92.2M
- IPO Year
- TLSI N/A
- QIPT N/A
- Fundamental
- Price
- TLSI $4.74
- QIPT $1.97
- Analyst Decision
- TLSI Strong Buy
- QIPT Buy
- Analyst Count
- TLSI 5
- QIPT 2
- Target Price
- TLSI $10.90
- QIPT $2.85
- AVG Volume (30 Days)
- TLSI 153.4K
- QIPT 561.8K
- Earning Date
- TLSI 08-13-2025
- QIPT 08-13-2025
- Dividend Yield
- TLSI N/A
- QIPT N/A
- EPS Growth
- TLSI N/A
- QIPT N/A
- EPS
- TLSI N/A
- QIPT N/A
- Revenue
- TLSI $32,141,000.00
- QIPT $240,848,000.00
- Revenue This Year
- TLSI $55.52
- QIPT $3.35
- Revenue Next Year
- TLSI $54.76
- QIPT $5.39
- P/E Ratio
- TLSI N/A
- QIPT N/A
- Revenue Growth
- TLSI 46.20
- QIPT N/A
- 52 Week Low
- TLSI $3.50
- QIPT $1.35
- 52 Week High
- TLSI $6.04
- QIPT $4.07
- Technical
- Relative Strength Index (RSI)
- TLSI 40.45
- QIPT 52.87
- Support Level
- TLSI $4.85
- QIPT $1.72
- Resistance Level
- TLSI $5.03
- QIPT $1.92
- Average True Range (ATR)
- TLSI 0.28
- QIPT 0.08
- MACD
- TLSI -0.04
- QIPT 0.01
- Stochastic Oscillator
- TLSI 2.73
- QIPT 80.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.